Role of racemization in optically active drugs development.
about
An Integrated Experimental and Computational Approach for Characterizing the Kinetics and Mechanism of Triadimefon Racemization.Chiral discrimination by vibrational spectroscopy utilizing local modes.Chiral toxicology: it's the same thing...only different.Enantio-separation of drugs with multiple chiral centers by chromatography and capillary electrophoresis.Enantiomeric resolution of multiple chiral centres racemates by capillary electrophoresis.Double-layered hyaluronic acid/stearic acid-modified polyethyleneimine nanoparticles encapsulating (-)-gossypol: a nanocarrier for chiral anticancer drugs.Luminescent chiral lanthanide(III) complexes as potential molecular probesProcesses to separate enantiomers.Chiral separation of quinolones by liquid chromatography and capillary electrophoresis.Distinct enantiomeric signals of ibuprofen and naproxen in treated wastewater and sewer overflow.A 3-D open-framework material with intrinsic chiral topology used as a stationary phase in gas chromatography.Enantiomeric resolution and modeling of DL-alanine-DL-tryptophan dipeptide on amylose stationary phase.Chemical chiral pollution: Impact on the society and science and need of the regulations in the 21st century.Quantitative Prediction of Rate Constants for Aqueous Racemization To Avoid Pointless Stereoselective Syntheses.Fast Screening of Whole Blood Samples and Pharmaceutical Compounds for Enantiorecognition of Free L-T3 , L-T4 , and D-T4.Controlled release of an optically active compound by hydrogels of acrylic acid and its online detectionChiral HPLC Separation and Modeling of Four Stereomers of DL-Leucine-DL-Tryptophan Dipeptide on Amylose Chiral ColumnChiral resolution of multichiral center racemates by different modalities of chromatographyEnantiomeric Separation and Simulation Studies of Pheniramine, Oxybutynin, Cetirizine, and Brinzolamide Chiral Drugs on Amylose-Based Columns
P2860
Q31118913-E4647824-7936-4559-8ADD-E45EFEEF78C3Q34555433-323AE42D-9B6E-478E-A28A-E5CE77BD5EE6Q34979115-68D8471E-4C6C-475B-B440-99B61E4A0AA4Q35213968-144EAE04-A74A-4FA0-9C52-BF38630BD97AQ35912976-F2D47356-455A-4FB0-9640-7B7B962969E5Q36584941-7FD53349-5612-4536-879B-79EE0CE5EA4EQ37445128-6414817C-DC4D-4BC8-AD6E-0CAC93882C00Q38180013-73005977-2BF3-48DA-A495-993C522A1BA2Q39311454-EFAC84E8-58FF-47A3-9EA6-C2203B81B242Q43327342-3AFA93CC-C0AB-406C-A089-FA7883603643Q44914856-BE6C3965-AE4E-495D-8F93-9969E57880A7Q47189460-A6254A9D-9302-4DB3-BE2D-AB3C3C2F12F0Q47269208-1F58BA52-66D2-4C1A-85DF-3B258299F386Q48125172-E473259D-97B4-4471-97C8-DA0D6A49483CQ53787034-0438DFCF-AD2E-493C-A438-0B168D9FE92FQ57348648-2359DB0E-253A-4EA1-B7E4-4EE07C34CA15Q59150020-D40253A2-F6DA-492D-ACEE-6609F2E481F9Q59150021-60E5FB01-5676-4709-8245-FED19841E7E1Q59150090-9B640A31-05DA-439C-98B7-07FCF4E979D7
P2860
Role of racemization in optically active drugs development.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Role of racemization in optically active drugs development.
@ast
Role of racemization in optically active drugs development.
@en
type
label
Role of racemization in optically active drugs development.
@ast
Role of racemization in optically active drugs development.
@en
prefLabel
Role of racemization in optically active drugs development.
@ast
Role of racemization in optically active drugs development.
@en
P2093
P2860
P356
P1433
P1476
Role of racemization in optically active drugs development
@en
P2093
Bhavtosh Sharma
Hassan Y Aboul-Enein
Prashant Singh
Vinod K Gupta
P2860
P304
P356
10.1002/CHIR.20397
P50
P577
2007-06-01T00:00:00Z